Skip to main content

Advertisement

Table 4 Relation between miRs and demographic, clinical and pathologic findings in both groups

From: Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules

  miR-222 miR-181a miR-155-5-P miR-146a
Pre-op Post-op Pre-op Post-op Pre-op Post-op Pre-op Post-op
Age Case 0.95 0.96 0.20 0.46 0.32 0.28 0.41 0.60
Control 0.67 0.10 0.01 0.05 0.60 0.67 0.43 0.41
Lymphadenectomy Case 0.25 0.10 0.42 0.46 0.30 0.24 0.28 0.14
Control  
Lymph node involvement Case 0.24 0.31 0.59 0.28 0.50 0.45 0.32 0.09
Control  
Sex Case 0.03 0.46 0.006 0.12 0.42 0.50 0.20 0.16
Control 0.18 0.41 0.08 0.05 0.39 0.32 0.27 0.49
Size Case 0.95   0.04   0.38   0.78  
Control 0.32 0.65 0.13 0.14
BRAFV600E Case < 0.001 0.98 0.60 0.64 0.30 0.30 < 0.001 < 0.001
Control 0.22 0.86 0.60 0.52 0.32 0.32 0.18 0.18
Capsular involvement Case 0.15 0.66 0.09 0.83 0.11 0.11 0.71 0.80
Control 0.27 0.13 0.26 0.24 0.59 0.52 0.04 0.01
Involved lobe of thyroid Case 0.66 0.28 0.71 0.36 0.47 0.47 0.57 0.62
Control 0.72 0.45 0.87 0.02 0.43 0.40 0.96 0.87
  1. All P-values were obtained by Mann-Whitney U test, whereas the significant findings are italic